Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Cala, founded in 2014 and headquartered in San Mateo, California, is a medical technology company specializing in neuro-peripheral therapy. The company develops wearable neuromodulation therapies that deliver individualized peripheral nerve stimulation to reduce tremors. With a focus on innovative medical solutions, Cala has positioned itself as a player in the healthcare technology sector.
Since its inception, Cala has raised a total of $157 million in funding, demonstrating investor interest in its unique approach to tremor management. The company's wearable devices offer a non-invasive alternative for patients seeking tremor reduction, potentially addressing a significant market need.
While there is often interest in the potential for companies like Cala to go public, we have not found any concrete news or reports regarding Cala's IPO prospects at this time. It's important to note that the decision to pursue an initial public offering involves various factors, including market conditions, company readiness, and strategic goals.
For investors interested in the medical technology sector, it's worth keeping an eye on Cala's developments. However, as with any private company, opportunities to invest in Cala stock or buy Cala shares are currently limited to private investment rounds. Should Cala decide to go public in the future, potential investors would need to wait for an official announcement and follow the standard procedures for participating in an IPO.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Cala's IPO prospects remain uncertain, investors interested in the fashion technology sector don't have to wait on the sidelines. At Linqto, we offer members access to interests in promising pre-IPO companies, including potential innovators in the fashion and tech industries. Our platform allows you to diversify your portfolio with lower minimum investments in emerging leaders like Cala, potentially benefiting from their growth before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
